Orthofix (NSDQ:OFIX) said it’s splitting its global spine business into 2 segments and re-organizing its management.

The Lewisville, Texas-based medical device company said it plans to create a biostim division and a spine fixation division out of its spine business, meaning the exit of global spine president Brian McCollum as of July 15. Brad Niemann is slated for promotion from commercial operations SVP to lead the biostim division. Orthofix president & CEO Brad Mason will lead the spine fixation division while the company looks for a permanent replacement, according to a press release.

Orthofix also tapped Mark Atkinson for its newly created "chief people officer" role, effective immediately; Michael Finegan as chief strategy officer; and Jeff Schumm as chief administrative officer.

"These organization changes are part of our overall strategic initiative to provide more operational focus on our businesses while driving enhanced shareholder value," Mason said in prepared remarks. "On behalf of Orthofix, I would like to welcome both Mark and Brad to the senior management team, congratulate Mike and Jeff on their expanded roles, and thank Brian for his many contributions and years of service to our company and wish him success in his future endeavors. We are creating a strong leadership team of talented employees at Orthofix and these promotions and appointments, together with our organization changes will advance our objectives for the benefit of our many stakeholders."

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW